231
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Three Generations of Ongoing Controversies Concerning the Use of Short Acting Beta-Agonist Therapy in Asthma: A Review

, M.D., Ph.D., M.P.H.
Pages 9-18 | Published online: 02 Jul 2009
 

Abstract

An increase in asthma mortality in 1960s noted by British authors stirred a debate about the use of beta-adrenergic therapy that has persisted in the medical literature. The cause appears to be isoproterenol and fenoterol overuse. A second debate evolved around the possible deleterious, pro-inflammatory effects, of the albuterol distomer. Most clinical studies showed improved bronchodilatation, but limited benefits from using levalbuterol. Recently, genotyping has uncovered a single nucleotide polymorphism at codon 16 that appears to affect the long term response to both regular and as needed use of albuterol, calling for a new genotype based therapeutic approach in asthma.

Abbreviations
β=

beta

FEV1=

the mean forced expiratory volume in 1 second

hBSMC=

human bronchial smooth muscle cells

IBMX=

isobutyl methylxanthine

Ca2+=

Calcium ion

GM-CSF=

granulocyte-macrophage colony stimulating factor

Arg16=

arginine16

NADPH=

the reduced form of the nicotinamide adenine dinucleotide phosphate-oxidase

NFκB=

nuclear factor kappa B

PEFR=

peak expiratory flow rate

Gly16=

glycine16

Gln27=

glutamine27

Glu27=

glutamic acid 27

Gs=

stimulatory G protein

Gi=

inhibitory G protein

SNP=

single nucleotide polymorphism

Abbreviations
β=

beta

FEV1=

the mean forced expiratory volume in 1 second

hBSMC=

human bronchial smooth muscle cells

IBMX=

isobutyl methylxanthine

Ca2+=

Calcium ion

GM-CSF=

granulocyte-macrophage colony stimulating factor

Arg16=

arginine16

NADPH=

the reduced form of the nicotinamide adenine dinucleotide phosphate-oxidase

NFκB=

nuclear factor kappa B

PEFR=

peak expiratory flow rate

Gly16=

glycine16

Gln27=

glutamine27

Glu27=

glutamic acid 27

Gs=

stimulatory G protein

Gi=

inhibitory G protein

SNP=

single nucleotide polymorphism

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.